Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.
about
In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography.Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints.The role and clinical implications of G6PI in experimental models of rheumatoid arthritisA functional variant of Fcgamma receptor IIIA is associated with rheumatoid arthritis in individuals who are positive for anti-glucose-6-phosphate isomerase antibodies.Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomeraseB cell depletion reduces the number of autoreactive T helper cells and prevents glucose-6-phosphate isomerase-induced arthritisThe value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritisImmunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.Automated Quantification of Early Bone Alterations and Pathological Bone Turnover in Experimental Arthritis by in vivo PET/CT ImagingTherapeutic potential of anti-interleukin-17A aptamer: suppression of interleukin-17A signaling and attenuation of autoimmunity in two mouse models.Six-transmembrane epithelial antigen of prostate4 (STEAP4) is a tumor necrosis factor alpha-induced protein that regulates IL-6, IL-8, and cell proliferation in synovium from patients with rheumatoid arthritis.Multivariate analysis of flow cytometric data using decision treesPathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation.Retinal glycoprotein enrichment by concanavalin a enabled identification of novel membrane autoantigen synaptotagmin-1 in equine recurrent uveitisActivation of Invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritisRaised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritis.Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cellsProphylactic Injection of Recombinant Alpha-Enolase Reduces Arthritis Severity in the Collagen-Induced Arthritis Mice ModelCells of the synovium in rheumatoid arthritis. T lymphocytes.Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.Quantification of arthritic bone degradation by analysis of 3D micro-computed tomography data.Simultaneous inhibition of JAK and SYK kinases ameliorates chronic and destructive arthritis in mice.The complex role of Fcgamma receptors in the pathology of arthritis.Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis.Soluble alpha-enolase activates monocytes by CD14-dependent TLR4 signalling pathway and exhibits a dual function.Auto-antibodies and autoreactive T-cells in rheumatoid arthritis: pathogenetic players and diagnostic tools.A human and animal model-based approach to investigating the anti-inflammatory profile and potential of the 5-HT2B receptor antagonist AM1030.Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis.Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.Infection and autoimmunity: Lessons of animal models.Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis.Potential role of bacterial infection in autoimmune diseases: a new aspect of molecular mimicry.Lessons from animal models of arthritis over the past decade.Of mice and men: how animal models advance our understanding of T-cell function in RA.The role of antibodies in inflammatory arthritis.Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis?Old and new therapeutics for Rheumatoid Arthritis: in vivo models and drug development.Current prospects of type II interferon γ signaling and autoimmunity.In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis.
P2860
Q22000844-5F1FA329-4EAD-49BD-8E40-3524E4C76BBCQ22000849-0532F9E7-CF1D-46F8-A5B6-C464D7F05DC9Q24799403-0C47E189-55A5-43E1-9A81-2BB725B056D4Q24812682-6C312FFC-7BB1-4B2C-A58E-63FA2F2C4DBDQ24812914-B8680B77-EAEC-4A77-84A5-44AC5F8B8B0EQ28740546-4464FCA0-8EA4-44E3-B446-EA759479E3FCQ33458893-B99FD5C9-DC8D-4B8F-AD68-3012E43ECBE5Q33488354-2E357392-8EBF-464F-8BBB-E6BD252B7E2CQ33714969-378C2A6A-0559-4A11-9D9E-C4D18DBBEBCFQ33725862-F445148C-95B9-41A9-9355-5E050CC39B48Q34189142-56057F2D-84E0-484E-896F-4054359C8DADQ34224702-00876EE6-FD1D-4A51-8E66-4B61A3B38310Q34243404-A225E6CE-57AB-4AEC-9E09-C4479C8F633CQ34510602-2922273A-4D12-4DE9-A1E0-0132E074F0DCQ34516219-F506891F-097F-41B7-8722-51150F263BA3Q35555539-7E8C8143-0687-4F4F-9818-A5AD9BA01EA5Q35585748-7FCDFEE4-F34E-4269-A1AC-FE28A100D1D6Q35753838-48267612-2F97-40A4-B932-903B41E0AE2CQ35769049-F66BC378-9CF4-45C3-B94D-4B40592EA1DBQ35979391-19C7C964-969A-484C-B224-751B9FDB0195Q36307153-6F8EC218-BAD1-486D-88D9-4C8EF2A5E712Q36361686-AC0622DC-A410-4692-8C7C-8385725B93F9Q36624577-B9FBFB5A-5B55-4DB4-B9DE-B9F7905D04E2Q36718541-4E71B617-7F57-466F-8C9E-3D21B7E718EDQ36776946-6BAD4F14-36AB-48F0-A615-F06F201D4ED7Q36787717-37A651B1-8126-43B7-97FB-11CD817E4564Q37031192-291EFE2B-D753-4781-BEB7-E9636C186743Q37206933-1932AD50-C5BE-4899-9269-61B994548700Q37350921-E9F9485B-44A0-4D3B-AE89-33B7A4D4E566Q37531246-A16A626B-E90D-4028-ACC1-3A1106FA899BQ37571042-E0D2BD6E-D527-447A-BA35-AF8FE7D54764Q37617223-048BB637-D3A9-409F-91EF-5833C9FA9575Q37619719-0CE14611-0F47-4F4A-A600-74D181AC3A11Q37635735-CCF33361-B569-4BE0-BFDC-963EB9A49630Q37700794-206582EC-C599-4C06-8F1B-4E7B4DF50DE0Q37761101-5B6935D7-BDE0-44B5-94A8-EF955F872846Q38697262-1DF6DBDD-0CF1-44F6-869A-E0F875C34D30Q39399554-10F7C207-0D2B-457B-9D0B-73B8B68D016DQ40164249-CFB3F7A5-80A2-42A0-AB1A-E6EF26DAE0FAQ40886613-AA55E336-6232-49C7-86DB-3D073FB53075
P2860
Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@en
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@nl
type
label
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@en
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@nl
prefLabel
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@en
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@nl
P2093
P1476
Immunization with glucose-6-ph ...... in genetically unaltered mice.
@en
P2093
Bert Maier
David Schubert
Lars Morawietz
P304
P356
10.4049/JIMMUNOL.172.7.4503
P407
P577
2004-04-01T00:00:00Z